Mapping the Genetic Determinants of Pathogenicity and Plaque Phenotype in Swine Vesicular Disease Virus

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1999 Mar 12

PMID 10074117

Citations 12

Authors

T Kanno

D Mackay

T Inoue

G Wilsden

M Yamakawa

R Yamazoe

S Yamaguchi

J Shirai

P Kitching

Y Murakami

Affiliations

Soon will be listed here.

Abstract

A series of recombinant viruses were constructed using infectious cDNA clones of the virulent J1'73 (large plaque phenotype) and the avirulent H/3'76 (small plaque phenotype) strains of swine vesicular disease virus to identify the genetic determinants of pathogenicity and plaque phenotype. Both traits could be mapped to the region between nucleotides (nt) 2233 and 3368 corresponding to the C terminus of VP3, the whole of VP1, and the N terminus of 2A. In this region, there are eight nucleotide differences leading to amino acid changes between the J1'73 and the H/3'76 strains. Site-directed mutagenesis of individual nucleotides from the virulent to the avirulent genotype and vice versa indicated that A at nt 2832, encoding glycine at VP1-132, and G at nt 3355, encoding arginine at 2APRO-20, correlated with a large-plaque phenotype and virulence in pigs, irrespective of the origin of the remainder of the genome. Of these two sites, 2APRO-20 appeared to be the dominant determinant for the large-plaque phenotype but further studies are required to elucidate their relative importance for virulence in pigs.

Citing Articles

Enhanced Pathogenic Consequences Induced by a Seven-Amino-Acid Extension in the G Protein of the HRSV BA9 Genotype.

Wang N, Song J, Cao L, Mao N, Shi Y, Jiang J Int J Mol Sci. 2025; 26(5).

PMID: 40076707 PMC: 11900327. DOI: 10.3390/ijms26052081.

An immortalized porcine macrophage cell line competent for the isolation of African swine fever virus.

Masujin K, Kitamura T, Kameyama K, Okadera K, Nishi T, Takenouchi T Sci Rep. 2021; 11(1):4759.

PMID: 33637799 PMC: 7910288. DOI: 10.1038/s41598-021-84237-2.

Characterization of Plaque Variants and the Involvement of Quasi-Species in a Population of EV-A71.

Mandary M, Masomian M, Ong S, Poh C Viruses. 2020; 12(6).

PMID: 32560288 PMC: 7354493. DOI: 10.3390/v12060651.

Infective viruses produced from full-length complementary DNA of swine vesicular disease viruses HK/70 strain.

Zheng H, Liu X, Shang Y, Wu J, Bai X, Jin Y Chin Sci Bull. 2020; 51(17):2072-2078.

PMID: 32214723 PMC: 7089143. DOI: 10.1007/s11434-006-2095-z.

Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.

Wang Y, Pfeiffer J mBio. 2016; 7(2):e00119.

PMID: 27025249 PMC: 4817249. DOI: 10.1128/mBio.00119-16.

References

Hambidge S, Sarnow P . Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A. Proc Natl Acad Sci U S A. 1992; 89(21):10272-6. PMC: 50320. DOI: 10.1073/pnas.89.21.10272. View

Tatem J, Georgiu A, DiMichele S, Gorgacz E, Racaniello V, Cano F . A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol. 1992; 66(5):3194-7. PMC: 241086. DOI: 10.1128/JVI.66.5.3194-3197.1992. View

Caggana M, Chan P, Ramsingh A . Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol. 1993; 67(8):4797-803. PMC: 237866. DOI: 10.1128/JVI.67.8.4797-4803.1993. View

Inoue T, Yamaguchi S, Kanno T, Sugita S, Saeki T . The complete nucleotide sequence of a pathogenic swine vesicular disease virus isolated in Japan (J1'73) and phylogenetic analysis. Nucleic Acids Res. 1993; 21(16):3896. PMC: 309922. DOI: 10.1093/nar/21.16.3896. View

Molla A, Paul A, Schmid M, Jang S, Wimmer E . Studies on dicistronic polioviruses implicate viral proteinase 2Apro in RNA replication. Virology. 1993; 196(2):739-47. DOI: 10.1006/viro.1993.1531. View

Macadam A, Ferguson G, Fleming T, Stone D, Almond J, Minor P . Role for poliovirus protease 2A in cap independent translation. EMBO J. 1994; 13(4):924-7. PMC: 394893. DOI: 10.1002/j.1460-2075.1994.tb06336.x. View

Zoll J, Galama J, Melchers W . Intratypic genome variability of the coxsackievirus B1 2A protease region. J Gen Virol. 1994; 75 ( Pt 3):687-92. DOI: 10.1099/0022-1317-75-3-687. View

Lu H, Yang C, Murdin A, Klein M, Harber J, Kew O . Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro. J Virol. 1994; 68(11):7507-15. PMC: 237193. DOI: 10.1128/JVI.68.11.7507-7515.1994. View

Zhang H, Blake N, Ouyang X, Pandolfino Y, Morgan-Capner P, Archard L . A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model. Arch Virol. 1995; 140(5):959-66. DOI: 10.1007/BF01314972. View

10.

Nardelli L, Lodetti E, Gualandi G, Burrows R, Goodridge D, Brown F . A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature. 1968; 219(5160):1275-6. DOI: 10.1038/2191275a0. View

11.

GRAVES J . Serological relationship of swine vesicular disease virus and Coxsackie B5 virus. Nature. 1973; 245(5424):314-5. DOI: 10.1038/245314a0. View

12.

Brown F, Talbot P, Burrows R . Antigenic differences between isolates of swine vesicular disease virus and their relationship to Coxsackie B5 virus. Nature. 1973; 245(5424):315-6. DOI: 10.1038/245315a0. View

13.

Brown F, Wild T, ROWE L, Underwood B, Harris T . Comparison of swine vesicular disease virus and Coxsackie B5 virus by serological and RNA hybridization methods. J Gen Virol. 1976; 31(2):231-7. DOI: 10.1099/0022-1317-31-2-231. View

14.

NAKANO J, HATCH M, Thieme M, Nottay B . Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol. 1978; 24:178-206. View

15.

Kodama M, Saito T, Ogawa T, Tokuda G, Sasahara J, Kumagai T . Swine vesicular disease viruses isolated from healthy pigs in non-epizootic period. II. Vesicular formation and virus multiplication in experimentally inoculated pigs. Natl Inst Anim Health Q (Tokyo). 1980; 20(4):123-30. View

16.

Racaniello V, Baltimore D . Cloned poliovirus complementary DNA is infectious in mammalian cells. Science. 1981; 214(4523):916-9. DOI: 10.1126/science.6272391. View

17.

Tu Z, Chapman N, HUFNAGEL G, Tracy S, Romero J, Barry W . The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol. 1995; 69(8):4607-18. PMC: 189260. DOI: 10.1128/JVI.69.8.4607-4618.1995. View

18.

Bouchard M, Lam D, Racaniello V . Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol. 1995; 69(8):4972-8. PMC: 189313. DOI: 10.1128/JVI.69.8.4972-4978.1995. View

19.

Ramsingh A, Collins D . A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J Virol. 1995; 69(11):7278-81. PMC: 189653. DOI: 10.1128/JVI.69.11.7278-7281.1995. View

20.

Kanno T, Inoue T, Wang Y, Sarai A, Yamaguchi S . Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants. J Gen Virol. 1995; 76 ( Pt 12):3099-106. DOI: 10.1099/0022-1317-76-12-3099. View